about
New concepts for an old problem: the diagnosis of endometrial hyperplasiaComplex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapyClinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia.Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.Biomarkers of progestin therapy resistance and endometrial hyperplasia progression.PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasiaClinical and pathological correlations in endometrial pathology.Clinco-Pathological Patterns in Women with Dysfunctional Uterine Bleeding.LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trialThe incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study.Conservative management of young patients with endometrial highly-differentiated adenocarcinoma.Recurrent endometrial hyperplasia as a presentation of estrogen-secreting thecoma - case report and minireview of the literature.Association of endometrial hyperplasia and cancer with a history of gestational diabetes.Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan.Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women's Health Across the Nation.Immunohistochemical Study of ER, PR, Ki67 and p53 in Endometrial Hyperplasias and Endometrial Carcinomas.Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series.New classification system of endometrial hyperplasia WHO 2014 and its clinical implications.Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses
P2860
Q28071864-48EEC677-4011-4616-887C-F6D3DA27422DQ34173018-E1EC46D8-9A14-479E-9BA7-20F61A1C989FQ34718198-2F05D54D-32BE-4DA3-8886-D37825696925Q35176084-35E5A4FF-3003-467C-95A4-46F33F384C24Q36099979-D211C8A9-9CA8-42E5-91EC-36E71A2B6A42Q36283995-58A242E7-7A11-40F9-AFEC-DFB7BFDD8CEEQ36310012-CB41E33A-DD48-4F02-9E4E-898A72421544Q36567597-6F10F514-F05B-4D0E-9E88-DED0F9229EE1Q36817480-1604C7AE-4D62-4F42-9F8F-E6F50AE2A774Q37234088-69F435AC-0933-48C0-9CA5-ABB51DBB0D68Q37833620-B0478832-4F41-4DC0-9F88-4496F819B889Q38639148-173D6F78-6D98-4874-AB6A-B294FEDB492DQ38675379-A7115AAF-56FC-4F80-8CD9-A09C095917D0Q39658317-E8EEBDC6-8ABC-4AFB-91EE-135FE46F0B17Q40262415-BD26B03C-BF45-458A-888E-FD70973740ACQ42255631-BB01DAF4-ECD8-4F42-9343-37D66A445A93Q46445529-847D39BF-8E22-4557-82BA-0E78158D0D6BQ52366406-5E6AFDAE-A04B-4F84-A2E1-DE7D6FFD9D2EQ57819009-0873BEF2-6947-4175-B80C-8CD9F64DACF2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Incidence of endometrial hyperplasia.
@en
Incidence of endometrial hyperplasia.
@nl
type
label
Incidence of endometrial hyperplasia.
@en
Incidence of endometrial hyperplasia.
@nl
prefLabel
Incidence of endometrial hyperplasia.
@en
Incidence of endometrial hyperplasia.
@nl
P2093
P2860
P1476
Incidence of endometrial hyperplasia.
@en
P2093
Katherine M Newton
Kimberly Allison
Lynda F Voigt
Noel S Weiss
Rochelle Garcia
Susan D Reed
Walter L Clinton
P2860
P304
P356
10.1016/J.AJOG.2009.02.032
P407
P577
2009-04-23T00:00:00Z